Cost-Containment

About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey report by three researchers at RAND.

Employers and benefits advisors are facing a growing challenge: How to offer access to these high-demand, life-changing therapies without undermining the financial sustainability of their health plans.

An advocate told state insurance regulators that the ACA alternative coverage can cut costs by 30% or more.

For employers, the agreement could mean that coverage from the Blues will be cheaper but more complicated.

Dr. Flanagan shares his thoughts on the history of direct-primary care, predicts where it's headed, and prescribes "the best drugs out there." Spoiler alert: it's not GLP-1s!

High-risk organizations need to pay close attention to anti-phishing safeguards and training at their vendors and service providers, because Scattered Spider members often use those to get into the targeted company, Toomey said.